EQUASENS : BILAN SEMESTRIEL S1-2024 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT Villers-lès-Nancy, le 05...
Equasens: RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 27 JUNE 2024 ...
Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS Villers-lès-Nancy, 10 June...
EQUASENS : Chiffre d’affaires T1 2024 Villers-lès-Nancy, le 7 mai 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires T1 2024 à...
EQUASENS : Modalités de mise à disposition de l'URD 2023 Villers-lès-Nancy, le 30 avril 2024 – 18 :45 (CET) COMMUNIQUE DE PRESSEPour...
Equasens: 2023 Annual Results Villers-lès-Nancy, 29 March 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 Annual Results Annual results...
EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE Villers-lès-Nancy, le 07 février 2024 - 18h30 (CET) COMMUNIQUE DE PRESSE...
Equasens: 2023 revenue: €219.7m, +2.6% Villers-lès-Nancy, 6 February 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 revenue: €219.7m, +2.6...
EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE Villers-lès-Nancy, le 2 janvier 2024 – 18:00 (CET) COMMUNIQUE DE PRESSE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.